Clinical Trials Browser

Completed × Melanoma × tilsotolimod × Clear all

NCT02644967 2022-08-03

ILLUMINATE-204

Phase 2 Completed

53 enrolled 21 charts

Melanoma

NCT03052205 2020-02-11

ILLUMINATE-101

Phase 1 Completed

Melanoma